Unbiased AI-powered news
3 stories related to this topic, newest first.
thegatewaypundit.comThree medicines scheduled to launch in the coming months will be the first priced under agreements President Trump reached with 17 drugmakers. The deals require U.S. net prices roughly equal to those in other wealthy nations.
cnbc.comLeerink analysts upgraded Johnson & Johnson shares to a buy equivalent from hold on Wednesday, pointing to momentum from recently launched medicines. The firm raised its price target to $265 per share and lifted sales growth forecasts. Johnson & Johnson shares rose more than 2 pe…
news18.comFrance's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…